maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
Published 2 years ago • 1.8K plays • Length 33:06Download video MP4
Download video MP3
Similar videos
-
57:33
immunotherapy as a treatment cornerstone for advanced endometrial cancer
-
37:54
clinical decision making with immunotherapies in advanced or recurrent endometrial cancer
-
36:22
modern, molecularly informed therapy for patients with advanced endometrial cancer
-
0:50
role of immunotherapy in advanced endometrial cancer: recent developments and future directions
-
28:45
refining the role of immune checkpoint inhibitors in endometrial cancer
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
57:40
immunotherapy in endometrial cancer: expanding horizons
-
49:48
new horizons for advanced endometrial cancer treatment
-
26:32
standard and alternative dosing regimens of immunotherapies and combinations in modern oncology
-
39:06
expanding the benefits of immuno-oncology through novel rational targets and combinations
-
20:43
updates in advanced & recurrent endometrial cancer: molecular classification & emerging therapies
-
0:47
assessing chemotherapy and immunotherapy in dmmr endometrial cancer
-
33:17
maximizing the benefits and minimizing the risks of cancer immunotherapies
-
0:37
importance of understanding molecular subtypes in endometrial cancer
-
1:22
dr. zamarin on the role of pembrolizumab in endometrial cancer
-
1:17:35
redefining endometrial and ovarian carcinoma care
-
52:53
immunotherapy in advanced endometrial cancer – the new standard of care
-
27:39
immunotherapy approaches in front-line advanced/recurrent endometrial cancer
-
1:01:26
practical perspectives on rapid change in endometrial and cervical cancer management